Slagle Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Slagle Financial's GILD Position: Q2 2026 in Review
Slagle Financial reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $5.01K and leaving 1,747 shares worth $221K. The position accounts for 0.07% of the portfolio, ranked #124.
Slagle Financial first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.6M in Q4 2024. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Slagle Financial held 1,747 shares of Gilead Sciences worth $221K as of Q2 2026.
- Slagle Financial sold 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
- Gilead Sciences made up 0.07% of Slagle Financial's portfolio in Q2 2026, its #124 holding.
- Slagle Financial first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
- Slagle Financial's Gilead Sciences position peaked at $2.6M in Q4 2024.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Slagle Financial's 13F filing for Q2 2026, filed 29 Jul 2026.